{"nct_id":"NCT04209114","title":"A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer","status":"COMPLETED","status_verified_date":"2024-06","start_date":"2020-02-05","start_date_type":"ACTUAL","primary_completion_date":"2023-06-07","primary_completion_date_type":"ACTUAL","completion_date":"2023-06-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}